UK company record
Healx
AI drug discovery (rare disease); AI drug discovery (rare disease) — borderline biotech/healthtech
CandidateCore UK
Snapshot
- UK location
- Cambridge · East of England
- Sector
- Biotech & techbio
- Latest recorded round
- Series C
- Latest recorded amount
- $47M / £37M
- Date
- 2024-08-01
Legal-identity layer
Candidate identity.
- Selected legal name
- HEALX LIMITED
- Company number
- 09018507
- Companies House status
- active
- Incorporated
- 2014-04-30
Investors
- AtomicoLead
- Ayana CapitalParticipant
- Balderton CapitalParticipant
- btov PartnersParticipant
- Global BrainParticipant
- Jonathan MilnerParticipant
- o2hParticipant
- o2h VenturesParticipant
- R42 GroupLead
- VU Venture PartnersParticipant
Current directors and active controllers
- BROWN, David, DrCurrent director
- CHANDRATILLAKE, Suranga, Mr.Current director
- CONNELL, Laura ElizabethCurrent director
- GUILLIAMS, Tim Thomas, DrCurrent director
- MILNER, Jonathan Simon, DrCurrent director
- OHS SECRETARIES LIMITEDCurrent director
- Dr Tim Thomas GuilliamsFormer controller
- GRADY, Shaun Francisdirector
- HAIVAS, Irina Elenadirector
- NAG, Ronjon, Professordirector
Funding rows
- Series C$47M / £37M · 2024-08-01
Sources
- https://techcrunch.com/2024/08/01/healx-an-ai-enabled-drug-discovery-platform-for-rare-diseases-raises-47m/
- https://www.uktech.news/medtech/healx-series-c-round-20240802
- https://healx.ai/healx-announces-47-million-series-c-financing-and-fda-clearance-of-phase-2-ind-for-neurofibromatosis-type-1-trial/
- https://www.finsmes.com/2024/08/healx-raises-47m-in-series-c-financing.html
- https://www.uktech.news/medtech/healx-series-c-round-20240802
- https://healx.ai/healx-announces-47-million-series-c-financing-and-fda-clearance-of-phase-2-ind-for-neurofibromatosis-type-1-trial/
- https://www.finsmes.com/2024/08/healx-raises-47m-in-series-c-financing.html